- Home
- PHM vs ZBH Comparison
PHM vs ZBH Comparison
Compare PHM & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHM
- ZBH
- Stock Information
- Founded
- PHM 1950
- ZBH 1927
- Country
- PHM United States
- ZBH United States
- Employees
- PHM N/A
- ZBH N/A
- Industry
- PHM Homebuilding
- ZBH Industrial Specialties
- Sector
- PHM Consumer Discretionary
- ZBH Health Care
- Exchange
- PHM Nasdaq
- ZBH Nasdaq
- Market Cap
- PHM 20.5B
- ZBH 21.9B
- IPO Year
- PHM N/A
- ZBH N/A
- Fundamental
- Price
- PHM $102.83
- ZBH $113.21
- Analyst Decision
- PHM Buy
- ZBH Buy
- Analyst Count
- PHM 16
- ZBH 22
- Target Price
- PHM $138.13
- ZBH $124.15
- AVG Volume (30 Days)
- PHM 2.3M
- ZBH 1.8M
- Earning Date
- PHM 04-22-2025
- ZBH 05-01-2025
- Dividend Yield
- PHM 0.86%
- ZBH 0.85%
- EPS Growth
- PHM 25.30
- ZBH N/A
- EPS
- PHM 14.69
- ZBH 4.43
- Revenue
- PHM $17,946,950,000.00
- ZBH $7,678,600,000.00
- Revenue This Year
- PHM $1.83
- ZBH $3.68
- Revenue Next Year
- PHM $5.91
- ZBH $4.53
- P/E Ratio
- PHM $7.00
- ZBH $25.54
- Revenue Growth
- PHM 11.74
- ZBH 3.85
- 52 Week Low
- PHM $99.58
- ZBH $97.69
- 52 Week High
- PHM $149.47
- ZBH $131.61
- Technical
- Relative Strength Index (RSI)
- PHM 44.33
- ZBH 62.40
- Support Level
- PHM $103.17
- ZBH $109.33
- Resistance Level
- PHM $106.94
- ZBH $112.31
- Average True Range (ATR)
- PHM 2.95
- ZBH 2.47
- MACD
- PHM 0.07
- ZBH 0.20
- Stochastic Oscillator
- PHM 40.93
- ZBH 93.05
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.